Lyric Bio, Inc.

About Lyric Bio, Inc.

Lyric Bio, Inc. is a biomanufacturing company focused on developing next-generation therapeutics manufacturing using human donor-derived biologics. Their mission is to eliminate global shortages of critical therapeutics by creating scalable manufacturing solutions for complex therapies, starting with human immunoglobulin (IvIg, ScIg), to reduce dependency on human plasma donations and improve access to life-saving treatments.

Products & Services

Human Immunoglobulin (IvIg, ScIg):A life-saving therapeutic used to treat over 100 diseases, produced using proprietary bioreactors that replicate biological tissue, significantly reducing the need for plasma donations by enabling production of over 1,000 doses from a single donor.

High-Density Tissue Mimicking Bioreactors:Innovative bioreactors leveraging proprietary laser-printed cellular substrates for ultra high-density cell growth, supporting continuous production of therapeutics from a single donor in a compact device.

Specialties

Biomanufacturing Tissue Engineering Human Immunoglobulin Production High-Density Bioreactor Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 6600000 MR: - FA: 6.6 million FAN: 6600000	D: 2025-12-02 FD: 2025-12-02	7 investors

Seed Latest

2025-12-02

$6.6M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Melanie P. Matheu

Co-founder & CSO

K

Kayj Shannon

Co-Founder & CEO

M

Melanie

Recent News

Lyric Bio, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised